Search results
RELIEF THERAPEUTICS Holding SA Announces Results of Extraordinary General Meeting
Digital Journal· 2 days agoTHERAPEUTICS Holding SA (SIX:RLF)(OTCQB:RLFTF, RLFTY) (Relief Therapeutics, or the Company), a biopharmaceutical company committed to ...
Onconic Therapeutics Receives MFDS Approval for JAQBO, a New Treatment for Gastroesophageal Reflux...
WKBN 27 Youngstown· 4 days agoOnconic Therapeutics, a leading biotechnology company in Korea, today announced that the Ministry of Food and Drug Safety (MFDS) of Korea has approved JAQBO ...
Radiance Biopharma to Present at LSX World Congress 2024
Digital Journal· 2 days agoThe newest, fastest-growing and most disruptive newswire available today. More from ACCESSWIRE Gaggia North America Introduces Espresso Evolution & MDF55 RELIEF< ...
The IPM-8221 – 8 Port Switched Power Manager by Planet Technology USA
Digital Journal· 2 days agoView the original press release on newswire.com. ACCESSWIRE News network reaching more than 1,500 media outlets in 98 countries. The newest, fastest-growing and most disruptive ...
Show Technology: Leading the Way in Premium LED Wall Rentals for Events Across the US
Digital Journal· 2 days agoThe newest, fastest-growing and most disruptive newswire available today. More from ACCESSWIRE Tax990 Helps ...America Introduces Espresso Evolution & MDF55 RELIEF ...
Napo Pharmaceuticals, a Jaguar Health Family Company, to Exhibit at Oncology Nursing Society (ONS)...
Digital Journal· 6 days agoSAN FRANCISCO, CA / ACCESSWIRE / April 22, 2024 / Jaguar Health, Inc. (NASDAQ:JAGX) ("Jaguar") today announced that Jaguar family company Napo Pharmaceuticals ("Napo") is ...
Caliway Announced CBL-514 Phase 2 Study for Cellulite Treatment Met All Primary and Secondary...
WCMH Columbus· 3 days agoCurrently, there is no effective and safe cellulite treatment on the market. The global market for cellulite treatment is estimated to expand to $7.37 billion in 2034. CBL-0201EFP Phase 2 study ...